We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$45.5B
AUM Growth
+$5.56B
Cap. Flow
+$2.53B
Cap. Flow %
5.56%
Top 10 Hldgs %
9.95%
Holding
3,224
New
651
Increased
711
Reduced
732
Closed
1,011

Sector Composition

Rank Sector Weight
1 Industrials 12.8%
2 Technology 12.79%
3 Consumer Discretionary 10.45%
4 Financials 8.11%
5 Healthcare 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOUG icon
2126
Douglas Elliman
DOUG
$187M
$32K ﹤0.01%
+14,409
New +$39.6K
NKGNW
2127
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$31.9K ﹤0.01%
140,000
NVTA
2128
DELISTED
Invitae Corporation
NVTA
$30.8K ﹤0.01%
27,242
-82,527
-75% -$104K
SID icon
2129
Companhia Siderúrgica Nacional
SID
$1.16B
$30.2K ﹤0.01%
11,648
-3,472
-23% -$9.57K
FFAI
2130
Faraday Future Intelligent Electric
FFAI
$9.92M
0
LTCH
2131
DELISTED
Latch, Inc. Common Stock
LTCH
$26K ﹤0.01%
+18,703
New +$17.5K
NKTR icon
2132
Nektar Therapeutics
NKTR
$2.58B
$25.6K ﹤0.01%
+2,965
New +$31.6K
SMMT icon
2133
Summit Therapeutics
SMMT
$12.2B
$25.5K ﹤0.01%
10,157
-25,406
-71% -$46.4K
RGTI icon
2134
Rigetti Computing
RGTI
$6B
$25.4K ﹤0.01%
+21,630
New +$16.2K
CMRX
2135
DELISTED
Chimerix, Inc.
CMRX
$24.6K ﹤0.01%
+20,314
New +$25.7K
OCGN icon
2136
Ocugen
OCGN
$471M
$23.1K ﹤0.01%
+42,478
New +$27.2K
ESPR
2137
DELISTED
Esperion Therapeutics
ESPR
$22.3K ﹤0.01%
16,039
-4,755,321
-100% -$6.64M
VXRT
2138
DELISTED
Vaxart
VXRT
$21.3K ﹤0.01%
+29,138
New +$27.1K
AFMD
2139
DELISTED
Affimed
AFMD
$20.1K ﹤0.01%
3,354
-2,984
-47% -$23.9K
SOND
2140
DELISTED
Sonder
SOND
$19K ﹤0.01%
+1,787
New +$19.4K
KRON
2141
DELISTED
Kronos Bio
KRON
$18.1K ﹤0.01%
+10,509
New +$16.7K
GOSS icon
2142
Gossamer Bio
GOSS
$87.8M
$17.6K ﹤0.01%
+14,690
New +$18.3K
BHACW
2143
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$17.3K ﹤0.01%
766,804
-223,196
-23% -$12K
BLEUW
2144
DELISTED
bleuacacia ltd Warrants
BLEUW
$15.8K ﹤0.01%
350,000
MAPS
2145
DELISTED
WM TECHNOLOGY INC A
MAPS
$15.6K ﹤0.01%
+18,665
New +$15.3K
SPIR icon
2146
Spire Global
SPIR
$569M
$14.3K ﹤0.01%
+3,474
New +$18.5K
LGVCW
2147
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$14.2K ﹤0.01%
150,000
ASTR
2148
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$14.1K ﹤0.01%
+2,553
New +$14.6K
FRBK
2149
DELISTED
Republic First Bancorp Inc
FRBK
$13.8K ﹤0.01%
+15,293
New +$17.5K
INSG icon
2150
Inseego
INSG
$84.2M
$13.7K ﹤0.01%
+2,133
New +$17.1K

Similar funds

Balyasny Asset Management's Q2 2023 Portfolio in Review

As of Q2 2023, Balyasny Asset Management held 3,224 positions worth $45.5B, up 14% from $39.9B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Balyasny Asset Management deployed $2.53B of net new capital in Q2 2023, opening 651 new positions and adding to 711 existing holdings. Its largest new stake was Waste Connections: 1,195,081 shares worth $171M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 11% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $202M trimmed.

  • Balyasny Asset Management's largest Q2 2023 buy was Waste Connections: 1,195,081 shares worth $171M.
  • Balyasny Asset Management added most to iShares Russell 2000 ETF in Q2 2023, an estimated $427M increase.
  • Balyasny Asset Management's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $202M.
  • Balyasny Asset Management fully exited Carrier Global in Q2 2023, selling an estimated $305M.
  • Balyasny Asset Management's ten largest holdings make up 9.9% of its $45.5B portfolio in Q2 2023.
  • Balyasny Asset Management opened 651 new positions and closed 1,011 in Q2 2023.
  • Balyasny Asset Management's portfolio value rose 14% quarter-over-quarter to $45.5B.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.